Mergers, Acquisitions and Takeovers Case Study

GlaxoSmithKline (GSK): Post Merger Growth Strategies

OR

Abstract:
GlaxoSmithKline (GSK) is one of the largest pharmaceutical companies in the world. It operates in two segments – pharmaceuticals and consumer healthcare. Since the merger of Glaxo Wellcome and SmithKline Beecham in 2000, the company has been reporting increasing financial returns. On one hand, the company is entering into collaborations, agreements and partnerships, restructuring its R&D (Research and Development) and expanding its product portfolio. On the other hand the company is facing stiff competition from its rivals and generic firms.

Pedagogical Objectives:

• To discuss GlaxoSmithKline's financial performance post-merger and the performance of its core products
• To discuss the initiatives taken for growth
• To discuss the future challenges and strategies ahead.

Keywords : Mergers, Acquisitions, Alliances Case Study;GlaxoSmithKline Incorporated; Glaxo Wellcome and SmithKline Beecham; American pharmaceutical industry; Consumer healthcare; Jean-Pierre Garnier; Product pipeline; Nutritional healthcare products; Centres of Excellence for Drug Discovery (CEDD); Therapeutic areas; Generic competition; Over the counter products; Wellbutrin; Growth strategy; Patented products; US Food and Drug Administration

Contents: 
Gsk: Post-Merger
Financial Performanceaftermerger
Core Productsof The Company
International Sales In 2003
Sales In The Us And Europe In 2003
Product Approvals In 2003
Researchand Development
Collaborations, Partnerships, Alliances And Agreements
Competitors